Developer docs
API playgroundTry for free, no card

Search company profiles

Immudex

Full company profile

uuid000ckrn

Namestring
Immudex
Legal namestring
Immudex ApS
Websiteurl
immudex.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Immudex ApS is a Danish-headquartered (Virum) biotechnology company founded in 2009 that develops and commercializes reagents for the quantitation, characterization, and generation of antigen-specific immune cells. Its core technology is the Dextramer® platform — MHC multimers assembled on a dextran backbone that provide high-avidity detection of antigen-specific T cells, B cells, CAR cells, and non-conventional T cell subsets (MAIT, NKT, NK) across flow cytometry, NGS, and single-cell multi-omics workflows. The portfolio is anchored by MHC I and MHC II Dextramer® reagents for flow cytometry, dCODE® Dextramer® (HiT, RiO, 10x formats) for NGS and BD Rhapsody™ / 10x Chromium integration, Klickmer®/dCODE Klickmer® for customizable B cell detection, CAR Dextramer® (CD19, BCMA, MSLN), and Xynapse™-T non-cellular scaffolds for antigen-specific T cell activation. Supporting products include U-Load® self-assembly reagents, easYmers® peptide-receptive monomers (via immunAware), disease-specific panels (including SARS-CoV-2), MR1/CD1d/HLA-E/HLA-G reagents, plus clinical-grade Dextramer® GMP and MHC Monomers (GMP) under ISO 13485:2016 certification and 21 CFR Part 820 compliance.

The company monetizes through one-time reagent sales, professional services (custom alleles, TCR solutions, pMHC binding screening, easYmers® on dextran, GMP production establishment), and clinical-grade reagent supply, with most pricing on a quote basis. Distribution is hybrid: a direct e-commerce storefront and dedicated field sales/product information/technical support teams, augmented by regional distributors across 16 countries in Europe, Americas, and Asia/Pacific including a dedicated Chinese-language channel. Customer segments span cell therapy developers (CAR-T/TCR-T), vaccine developers, immuno-oncology researchers, infectious disease researchers, academic laboratories, and clinical/medical device manufacturers — with named enterprise users including Immatics and Symphogen/Servier.

The intellectual property base is broad: granted dCODE® patents in the US, EU, Japan, Australia, Canada, Singapore, and Hong Kong, plus registered trademarks (Dextramer®, easYmers®, Xynapse™) and a catalog of 65+ alleles across human, primate, and mouse species. Strategic partnerships include Parean Biotechnologies (10x Genomics Certified Service Provider) and Ardigen (AI CRO for multi-omics data analysis), positioning Immudex within an end-to-end immune-monitoring workflow from reagent to bioinformatics insight.

Short descriptiontext

Immudex is a Danish biotechnology company that develops and commercializes Dextramer® MHC multimer reagents for detecting and characterizing antigen-specific T cells, B cells, and CAR cells. It serves cell therapy developers, vaccine researchers, immuno-oncology programs, and clinical laboratories with research and GMP-grade products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCopenhagen, Denmark
HQ citystring
Copenhagen
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immune monitoring reagents, MHC multimer technology, cell therapy reagents, antigen-specific T cell detection, flow cytometry reagents
Industry1 code
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Biological Products, (No Disgnostic Substances)2836
Product category
Immune Monitoring Reagents
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Research Reagent Sales
TypeOne Time License
Description

Sale of standardized Dextramer® reagents including MHC I/II Dextramer®, dCODE Dextramer®, Klickmer®, CAR Dextramer®, and related products for flow cytometry and multi-omics applications. Products available in various test sizes with multiple fluorophore options (PE, APC, FITC, BV421).

immudex.com
2Custom Solutions and Services
TypeProfessional Services
Description

Consulting and manufacturing services including custom alleles, custom Dextramer® reagents, TCR solutions, pMHC binding screening, easYmers® on dextran, and GMP production establishment. Projects assessed individually and matched to customer requirements.

immudex.com
3Clinical-Grade Reagents
TypeOne Time License
Description

GMP-grade MHC Dextramer® reagents and MHC monomers for lot-release testing of T cell therapies, clinical trials, and medical device manufacturing. Produced under ISO 13485:2016 certification with comprehensive documentation.

immudex.com
4Xynapse™ Reagent Sales
TypeOne Time License
Description

Sale of Xynapse™-T reagents for T cell stimulation and expansion, available in 100μl and 250μl sizes with pMHC/aCD28 configuration.

immudex.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure, Supply Chain
Pricing details4 tiers
1CAR Dextramer® catalog products - 50 test sizes with PE fluorophore
ModelUnit PricingBilling cadencePay-as-you-go
Notes

CT001 CAR Dextramer® CD19, CT003 CAR Dextramer® BCMA, CT006 CAR Dextramer® MSLN - all at 50 tests with PE dye. Pricing available on request.

immudex.com
2Xynapse™-T reagents - 100μl and 250μl sizes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Xynapse™-T pMHC/aCD28 available in 100μl or 250μl sizes. Recommended usage at 100x dilution (v/v). Pricing available on request.

immudex.com
3easYmers® on Dextran - multiple test sizes and fluorophore options
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Dextramer® reagents available with 50, 150, or 500 tests. Fluorophore options include BV421, PE, APC, FITC, or none. dCODE Dextramer® with DNA barcode available with 25, 50, 150, or 500 tests with PE fluorophore.

immudex.com
4Custom Solutions and Services
ModelOtherBilling cadenceMulti-year contract
Notes

Custom projects assessed individually based on scope, complexity, and resource needs. Includes TCR solutions, custom alleles, pMHC binding screening, and GMP production establishment.

immudex.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Immudex develops, manufactures, and commercializes Dextramer®-based biological reagents and related custom services for the detection, characterization, and generation of antigen-specific immune cells. Its portfolio spans flow cytometry reagents, DNA-barcoded reagents for NGS and single-cell multi-omics, GMP-grade clinical reagents, and T cell stimulation scaffolds, supported by a custom solutions team that develops new alleles, TCR reagents, and tailored assays for cell therapy developers, vaccine researchers, and academic immunology laboratories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 55% validation rate for dCODE® Klickmer identified antibodies in antibody discovery applications
+2 more records
Product overview1 text field

Immudex is a biotechnology company offering a comprehensive portfolio of Dextramer® reagents and services for immune-monitoring research and clinical applications. The core product line includes MHC I and II Dextramer® reagents for flow cytometry, dCODE Dextramer® products for NGS and single-cell multi-omics analysis, Klickmer® and dCODE Klickmer® for B-cell and customizable detection, CAR Dextramer® for CAR cell detection, and Xynapse™-T for T-cell stimulation. Supporting products include U-Load® reagents for lab-built Dextramers, Immudex Monomers (easYmers® MHC I, U-Load® MHC II, Soluble TCR Monomers), disease-specific panels (SARS-CoV-2, cancer, infectious disease), and MR1, CD1d, HLA-E/G products for non-conventional T cells and NK cells. Clinical-grade offerings include Dextramer® CMV Kit (IVD), Dextramer® GMP, and MHC Monomers (GMP). Custom Solutions and Services provide TCR Solutions, Custom Alleles, easYmers® on Dextran, pMHC Binding Screening, and Custom CAR Dextramer® for tailored research needs.

Product and service27 records
1MHC I Dextramer® - Flow Cytometry
CategoryCore Research Reagent
Description

Ready-to-use Dextramer® reagents for detection and quantification of antigen-specific CD8+ T cells by flow cytometry, delivering a strong signal-to-noise ratio for immune monitoring research.

2MHC II Dextramer® - Flow Cytometry
CategoryCore Research Reagent
Description

Ready-to-use Dextramer® reagents for detection and quantification of antigen-specific CD4+ T cells by flow cytometry.

3dCODE Dextramer® - NGS/Multi-omics
CategoryCore Research Reagent
Description

MHC Dextramer® reagents with unique DNA barcodes for analysis of antigen-specific T cells by NGS or single-cell multi-omics, offered in HiT (bulk NGS), RiO (BD Rhapsody™), and 10x (10x Chromium) formats.

4dCODE Klickmer®
CategoryCore Research Reagent
Description

Customizable analysis reagents for detection of antigen-specific immune cells by NGS or single-cell multi-omics, enabling B-cell specificity mapping and antibody discovery workflows.

5Klickmer®
CategoryCore Research Reagent
Description

Dextramer® technology combined with flexible customization for detecting antigen-specific B cells and other immune cells by flow cytometry.

6U-Load®
CategoryCore Research Reagent
Description

Build-your-own Dextramer® reagent system allowing researchers to assemble MHC monomers with their choice of peptide specificity in their own laboratory.

7U-Load dCODE Dextramer®
CategoryCore Research Reagent
Description

Flexible dCODE Dextramer® reagents that users can build with their choice of MHC complex and peptide for NGS or single-cell multi-omics analysis.

8CAR Dextramer®
CategoryCore Research Reagent
Description

Rapid one-step staining reagents for sensitive and robust detection of CAR cells, with catalog products covering CD19, BCMA, and mesothelin targets for CAR-T cell therapy development.

9Xynapse™-T - T Cell Stimulation
CategoryCore Research Reagent
Description

Non-cellular antigen-presenting scaffolds providing potent two-signal activation and expansion of T cells and TCR-engineered T cells by mimicking the TCR immunological synapse through pMHC-TCR interaction and CD28 engagement.

10MR1 Products
CategoryCore Research Reagent
Description

Reagents for reliable detection and characterization of antigen-specific MAIT (mucosal-associated invariant T) cells using MR1 Dextramer® technology.

11CD1d Products
CategoryCore Research Reagent
Description

Reagents for detection and characterization of CD1d-restricted NKT (natural killer T) cells using CD1d Dextramer® technology.

12HLA-E and HLA-G Products
CategoryCore Research Reagent
Description

Reagents for investigation of antigen-specific NK cell immune responses using HLA-E and HLA-G Dextramer® products.

13Immudex Monomers
CategoryCore Research Reagent
Description

High-quality MHC monomers, including easYmers® MHC I (powered by immunAware), U-Load® MHC II monomers, and Soluble TCR Monomers, for flexible applications including multimer assembly, T-cell stimulation, and TCR characterization.

14Dextramer® Controls
CategoryCore Research Reagent
Description

Quality control reagents for accurate distinction between background and antigen-specific staining, recommended for optimization of gating or sorting of positive cells.

15Disease Panels - Flow Cytometry
CategoryCore Research Reagent
Description

Pre-defined panels of selected Dextramer® reagents for disease-specific immune monitoring in cancer and infectious diseases, enabling detection and quantification of antigen-specific T cells without missing low-affinity cells.

16SARS-CoV-2 Dextramer® Reagents
CategoryCore Research Reagent
Description

Pre-defined SARS-CoV-2 Dextramer® Panels with curated selection of validated T-cell epitopes for monitoring T-cell immunity in COVID-19 research.

17Dextramer® - In Situ Staining
CategoryCore Research Reagent
Description

Reagents for visualization of tissue-specific immunity by tracking spatial distribution of antigen-specific immune cells in tissue via direct or indirect staining.

18Dextramer® CMV Kit - In Vitro Diagnostics
CategoryClinical Product
Description

In vitro diagnostic reagent for monitoring cytomegalovirus-specific T cells, supporting transplantation patient monitoring.

19Dextramer® GMP
CategoryClinical Product
Description

Clinical-grade MHC Dextramer® reagents produced in compliance with ISO 13485 and 21 CFR 820 for lot-release testing of T cell therapies.

20MHC Monomers (GMP)
CategoryClinical Product
Description

GMP-grade MHC monomers for applications requiring excellent quality reagents with high documentation, including LDT components, medical devices, clinical trials (GC(L)P), and manufacturing/QC of pharmaceutical products.

21Custom MHC Dextramer®
CategoryCustom Solution
Description

Custom-designed Dextramer® reagents with specific alleles and peptide specificities tailored to unique research requirements.

22TCR Solutions
CategoryCustom Service
Description

Custom production of TCR candidates as Soluble TCR Monomers or TCR Dextramer® reagents, supporting TCR discovery, validation, and characterization.

23Custom Alleles
CategoryCustom Service
Description

Manufacturing of new alleles on request, including feasibility assessment, design, development, and quality-controlled delivery of custom Dextramer® reagents or monomers.

24easYmers® on Dextran
CategoryCustom Service
Description

Custom service loading user-specified class I alleles with peptides of interest and assembling MHC monomers on a dextran backbone for ready-to-use Dextramer® reagents.

25pMHC Binding Screening
CategoryCustom Service
Description

Service evaluating the potential of user-specified peptides and alleles to form stable peptide-MHC complexes using semi-quantitative bead-based assays for epitope discovery and validation.

26Custom CAR Dextramer®
CategoryCustom Solution
Description

Custom CAR Dextramer® reagents produced to match user-specified target antigens for CAR cell detection and characterization.

27Dextramer® BV421
CategoryCore Research Reagent
Description

Dextramer® reagent offered in the BV421 fluorophore format for flow cytometry applications, providing additional fluorophore flexibility for antigen-specific immune cell monitoring panels.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Parean Biotechnologies
Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Parean Biotechnologies, a 10x Genomics Certified Service Provider, providing immune cell phenotyping services using dCODE® reagents. Parean offers expertise in flow cytometry, cell sorting, bulk and single-cell omics sequencing, and data analysis.

immudex.com
2Ardigen
Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Ardigen, a world-leading AI CRO, providing Immune Profiling Multi-Omics Data Analysis Services. Uses advanced platforms and expertise to transform multi-omics datasets generated using dCODE® reagents into ready-to-use scientific insights.

immudex.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

MBL International and its JPT Peptide Technologies division manufacture MHC multimers, tetramers, and peptide-MHC reagents for antigen-specific T cell detection — the most direct technology overlap with Immudex's Dextramer® platform.

TypeDirect peer
Description

ProImmune offers MHC-peptide tetramers, pentamers, and related immune monitoring reagents for antigen-specific T cell characterization, directly competing in the same reagent category as Immudex.

TypeBroad incumbent
Description

BioLegend (acquired by PerkinElmer/Sciex) is a major flow cytometry reagent vendor offering MHC tetramers and multimer products alongside a much broader catalog of immunology reagents, making it a broad incumbent competitor to Immudex.

4Beckman Coulter (Danaher)
TypeBroad incumbent
Description

Beckman Coulter Life Sciences sells MHC tetramers and a broad flow cytometry reagent portfolio, competing with Immudex in antigen-specific immune cell detection within a much larger parent company's catalog.

TypeBroad incumbent
Description

Thermo Fisher offers MHC Class I and II tetramers and immune monitoring reagents as part of its massive life-science tools catalog, representing a broad incumbent alternative to Immudex's specialty Dextramer® line.

TypeEmerging player
Description

10x Genomics provides the Chromium single-cell platform that dCODE® Dextramer® integrates with. While not a direct reagent competitor, it is a closely coupled platform player whose product roadmap and pricing directly affects Immudex's multi-omics reagent economics.

TypeEmerging player
Description

BD Biosciences offers the Rhapsody™ single-cell analysis platform that dCODE® Dextramer® (RiO) integrates with. Similar to 10x, BD is a coupled platform provider rather than direct competitor, but its single-cell ecosystem strategy intersects Immudex's multi-omics reagent business.

TypeBroad incumbent
Description

Cell Signaling Technology is a major immunology and cell biology reagent vendor offering flow cytometry products and antibody tools that overlap with Immudex's research reagent customer base, particularly in cancer immunology.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Immudex

Immune Monitoring Reagentsimmudex.com

Immudex is a Danish biotechnology company that develops and commercializes Dextramer® MHC multimer reagents for detecting and characterizing antigen-specific T cells, B cells, and CAR cells. It serves cell therapy developers, vaccine researchers, immuno-oncology programs, and clinical laboratories with research and GMP-grade products.

What Immudex does

Immudex ApS is a Danish-headquartered (Virum) biotechnology company founded in 2009 that develops and commercializes reagents for the quantitation, characterization, and generation of antigen-specific immune cells. Its core technology is the Dextramer® platform — MHC multimers assembled on a dextran backbone that provide high-avidity detection of antigen-specific T cells, B cells, CAR cells, and non-conventional T cell subsets (MAIT, NKT, NK) across flow cytometry, NGS, and single-cell multi-omics workflows. The portfolio is anchored by MHC I and MHC II Dextramer® reagents for flow cytometry, dCODE® Dextramer® (HiT, RiO, 10x formats) for NGS and BD Rhapsody™ / 10x Chromium integration, Klickmer®/dCODE Klickmer® for customizable B cell detection, CAR Dextramer® (CD19, BCMA, MSLN), and Xynapse™-T non-cellular scaffolds for antigen-specific T cell activation. Supporting products include U-Load® self-assembly reagents, easYmers® peptide-receptive monomers (via immunAware), disease-specific panels (including SARS-CoV-2), MR1/CD1d/HLA-E/HLA-G reagents, plus clinical-grade Dextramer® GMP and MHC Monomers (GMP) under ISO 13485:2016 certification and 21 CFR Part 820 compliance.

The company monetizes through one-time reagent sales, professional services (custom alleles, TCR solutions, pMHC binding screening, easYmers® on dextran, GMP production establishment), and clinical-grade reagent supply, with most pricing on a quote basis. Distribution is hybrid: a direct e-commerce storefront and dedicated field sales/product information/technical support teams, augmented by regional distributors across 16 countries in Europe, Americas, and Asia/Pacific including a dedicated Chinese-language channel. Customer segments span cell therapy developers (CAR-T/TCR-T), vaccine developers, immuno-oncology researchers, infectious disease researchers, academic laboratories, and clinical/medical device manufacturers — with named enterprise users including Immatics and Symphogen/Servier.

The intellectual property base is broad: granted dCODE® patents in the US, EU, Japan, Australia, Canada, Singapore, and Hong Kong, plus registered trademarks (Dextramer®, easYmers®, Xynapse™) and a catalog of 65+ alleles across human, primate, and mouse species. Strategic partnerships include Parean Biotechnologies (10x Genomics Certified Service Provider) and Ardigen (AI CRO for multi-omics data analysis), positioning Immudex within an end-to-end immune-monitoring workflow from reagent to bioinformatics insight.

Immudex firmographics

Firmographics
Name
Immudex
Legal name
Immudex ApS
Website
https://immudex.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Immudex is a Danish biotechnology company that develops and commercializes Dextramer® MHC multimer reagents for detecting and characterizing antigen-specific T cells, B cells, and CAR cells. It serves cell therapy developers, vaccine researchers, immuno-oncology programs, and clinical laboratories with research and GMP-grade products.
Ownership category
akta.pro rank

Immudex industry classification

Industry
Product category
Immune Monitoring Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Immune monitoring reagents
  • MHC multimer technology
  • Cell therapy reagents
  • Antigen-specific T cell detection
  • Flow cytometry reagents

Where Immudex is headquartered

Location

Headquarters

HQ city
Copenhagen
HQ country
Denmark
HQ region
Europe

Offices3 records

Markets served

Immudex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Research Reagent Sales: Sale of standardized Dextramer® reagents including MHC I/II Dextramer®, dCODE Dextramer®, Klickmer®, CAR Dextramer®, and related products for flow cytometry and multi-omics applications. Products available in various test sizes with multiple fluorophore options (PE, APC, FITC, BV421).
  2. Custom Solutions and Services: Consulting and manufacturing services including custom alleles, custom Dextramer® reagents, TCR solutions, pMHC binding screening, easYmers® on dextran, and GMP production establishment. Projects assessed individually and matched to customer requirements.
  3. Clinical-Grade Reagents: GMP-grade MHC Dextramer® reagents and MHC monomers for lot-release testing of T cell therapies, clinical trials, and medical device manufacturing. Produced under ISO 13485:2016 certification with comprehensive documentation.
  4. Xynapse™ Reagent Sales: Sale of Xynapse™-T reagents for T cell stimulation and expansion, available in 100μl and 250μl sizes with pMHC/aCD28 configuration.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCAR Dextramer® catalog products - 50 test sizes with PE fluorophore
Unit PricingPay-as-you-goXynapse™-T reagents - 100μl and 250μl sizes
Unit PricingPay-as-you-goeasYmers® on Dextran - multiple test sizes and fluorophore options
OtherMulti-year contractCustom Solutions and Services

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Immudex product offering

Product offering

Core offering

Immudex develops, manufactures, and commercializes Dextramer®-based biological reagents and related custom services for the detection, characterization, and generation of antigen-specific immune cells. Its portfolio spans flow cytometry reagents, DNA-barcoded reagents for NGS and single-cell multi-omics, GMP-grade clinical reagents, and T cell stimulation scaffolds, supported by a custom solutions team that develops new alleles, TCR reagents, and tailored assays for cell therapy developers, vaccine researchers, and academic immunology laboratories.

Product overview

Immudex is a biotechnology company offering a comprehensive portfolio of Dextramer® reagents and services for immune-monitoring research and clinical applications. The core product line includes MHC I and II Dextramer® reagents for flow cytometry, dCODE Dextramer® products for NGS and single-cell multi-omics analysis, Klickmer® and dCODE Klickmer® for B-cell and customizable detection, CAR Dextramer® for CAR cell detection, and Xynapse™-T for T-cell stimulation. Supporting products include U-Load® reagents for lab-built Dextramers, Immudex Monomers (easYmers® MHC I, U-Load® MHC II, Soluble TCR Monomers), disease-specific panels (SARS-CoV-2, cancer, infectious disease), and MR1, CD1d, HLA-E/G products for non-conventional T cells and NK cells. Clinical-grade offerings include Dextramer® CMV Kit (IVD), Dextramer® GMP, and MHC Monomers (GMP). Custom Solutions and Services provide TCR Solutions, Custom Alleles, easYmers® on Dextran, pMHC Binding Screening, and Custom CAR Dextramer® for tailored research needs.

Differentiator

Problem solved

Functional benefit

Products and services

  • MHC I Dextramer® - Flow Cytometry Ready-to-use Dextramer® reagents for detection and quantification of antigen-specific CD8+ T cells by flow cytometry, delivering a strong signal-to-noise ratio for immune monitoring research.
  • MHC II Dextramer® - Flow Cytometry Ready-to-use Dextramer® reagents for detection and quantification of antigen-specific CD4+ T cells by flow cytometry.
  • dCODE Dextramer® - NGS/Multi-omics MHC Dextramer® reagents with unique DNA barcodes for analysis of antigen-specific T cells by NGS or single-cell multi-omics, offered in HiT (bulk NGS), RiO (BD Rhapsody™), and 10x (10x Chromium) formats.
  • dCODE Klickmer® Customizable analysis reagents for detection of antigen-specific immune cells by NGS or single-cell multi-omics, enabling B-cell specificity mapping and antibody discovery workflows.
  • Klickmer® Dextramer® technology combined with flexible customization for detecting antigen-specific B cells and other immune cells by flow cytometry.
  • U-Load® Build-your-own Dextramer® reagent system allowing researchers to assemble MHC monomers with their choice of peptide specificity in their own laboratory.
  • U-Load dCODE Dextramer® Flexible dCODE Dextramer® reagents that users can build with their choice of MHC complex and peptide for NGS or single-cell multi-omics analysis.
  • CAR Dextramer® Rapid one-step staining reagents for sensitive and robust detection of CAR cells, with catalog products covering CD19, BCMA, and mesothelin targets for CAR-T cell therapy development.
  • Xynapse™-T - T Cell Stimulation Non-cellular antigen-presenting scaffolds providing potent two-signal activation and expansion of T cells and TCR-engineered T cells by mimicking the TCR immunological synapse through pMHC-TCR interaction and CD28 engagement.
  • MR1 Products Reagents for reliable detection and characterization of antigen-specific MAIT (mucosal-associated invariant T) cells using MR1 Dextramer® technology.
  • CD1d Products Reagents for detection and characterization of CD1d-restricted NKT (natural killer T) cells using CD1d Dextramer® technology.
  • HLA-E and HLA-G Products Reagents for investigation of antigen-specific NK cell immune responses using HLA-E and HLA-G Dextramer® products.
  • Immudex Monomers High-quality MHC monomers, including easYmers® MHC I (powered by immunAware), U-Load® MHC II monomers, and Soluble TCR Monomers, for flexible applications including multimer assembly, T-cell stimulation, and TCR characterization.
  • Dextramer® Controls Quality control reagents for accurate distinction between background and antigen-specific staining, recommended for optimization of gating or sorting of positive cells.
  • Disease Panels - Flow Cytometry Pre-defined panels of selected Dextramer® reagents for disease-specific immune monitoring in cancer and infectious diseases, enabling detection and quantification of antigen-specific T cells without missing low-affinity cells.
  • SARS-CoV-2 Dextramer® Reagents Pre-defined SARS-CoV-2 Dextramer® Panels with curated selection of validated T-cell epitopes for monitoring T-cell immunity in COVID-19 research.
  • Dextramer® - In Situ Staining Reagents for visualization of tissue-specific immunity by tracking spatial distribution of antigen-specific immune cells in tissue via direct or indirect staining.
  • Dextramer® CMV Kit - In Vitro Diagnostics In vitro diagnostic reagent for monitoring cytomegalovirus-specific T cells, supporting transplantation patient monitoring.
  • Dextramer® GMP Clinical-grade MHC Dextramer® reagents produced in compliance with ISO 13485 and 21 CFR 820 for lot-release testing of T cell therapies.
  • MHC Monomers (GMP) GMP-grade MHC monomers for applications requiring excellent quality reagents with high documentation, including LDT components, medical devices, clinical trials (GC(L)P), and manufacturing/QC of pharmaceutical products.
  • Custom MHC Dextramer® Custom-designed Dextramer® reagents with specific alleles and peptide specificities tailored to unique research requirements.
  • TCR Solutions Custom production of TCR candidates as Soluble TCR Monomers or TCR Dextramer® reagents, supporting TCR discovery, validation, and characterization.
  • Custom Alleles Manufacturing of new alleles on request, including feasibility assessment, design, development, and quality-controlled delivery of custom Dextramer® reagents or monomers.
  • easYmers® on Dextran Custom service loading user-specified class I alleles with peptides of interest and assembling MHC monomers on a dextran backbone for ready-to-use Dextramer® reagents.
  • pMHC Binding Screening Service evaluating the potential of user-specified peptides and alleles to form stable peptide-MHC complexes using semi-quantitative bead-based assays for epitope discovery and validation.
  • Custom CAR Dextramer® Custom CAR Dextramer® reagents produced to match user-specified target antigens for CAR cell detection and characterization.
  • Dextramer® BV421 Dextramer® reagent offered in the BV421 fluorophore format for flow cytometry applications, providing additional fluorophore flexibility for antigen-specific immune cell monitoring panels.

Quantifiable outcome

  • 55% validation rate for dCODE® Klickmer identified antibodies in antibody discovery applications
  • +2 more outcomes

Companies that use Immudex

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Immudex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability4 records

Feature9 records

Immudex partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Parean BiotechnologiescoreTechnology or IntegrationPartnership with Parean Biotechnologies, a 10x Genomics Certified Service Provider, providing immune cell phenotyping services using dCODE® reagents. Parean offers expertise in flow cytometry, cell sorting, bulk and single-cell omics sequencing, and data analysis.
  • ArdigencoreTechnology or IntegrationPartnership with Ardigen, a world-leading AI CRO, providing Immune Profiling Multi-Omics Data Analysis Services. Uses advanced platforms and expertise to transform multi-omics datasets generated using dCODE® reagents into ready-to-use scientific insights.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Immudex competitors and assessment

Company assessment

Direct peers

  • MBL International (JPT Peptide Technologies): MBL International and its JPT Peptide Technologies division manufacture MHC multimers, tetramers, and peptide-MHC reagents for antigen-specific T cell detection — the most direct technology overlap with Immudex's Dextramer® platform.
  • ProImmune: ProImmune offers MHC-peptide tetramers, pentamers, and related immune monitoring reagents for antigen-specific T cell characterization, directly competing in the same reagent category as Immudex.

Broad incumbents

  • BioLegend (PerkinElmer): BioLegend (acquired by PerkinElmer/Sciex) is a major flow cytometry reagent vendor offering MHC tetramers and multimer products alongside a much broader catalog of immunology reagents, making it a broad incumbent competitor to Immudex.
  • Beckman Coulter (Danaher): Beckman Coulter Life Sciences sells MHC tetramers and a broad flow cytometry reagent portfolio, competing with Immudex in antigen-specific immune cell detection within a much larger parent company's catalog.
  • Thermo Fisher Scientific: Thermo Fisher offers MHC Class I and II tetramers and immune monitoring reagents as part of its massive life-science tools catalog, representing a broad incumbent alternative to Immudex's specialty Dextramer® line.
  • Cell Signaling Technology (CST): Cell Signaling Technology is a major immunology and cell biology reagent vendor offering flow cytometry products and antibody tools that overlap with Immudex's research reagent customer base, particularly in cancer immunology.

Emerging players

  • 10x Genomics: 10x Genomics provides the Chromium single-cell platform that dCODE® Dextramer® integrates with. While not a direct reagent competitor, it is a closely coupled platform player whose product roadmap and pricing directly affects Immudex's multi-omics reagent economics.
  • BD Biosciences: BD Biosciences offers the Rhapsody™ single-cell analysis platform that dCODE® Dextramer® (RiO) integrates with. Similar to 10x, BD is a coupled platform provider rather than direct competitor, but its single-cell ecosystem strategy intersects Immudex's multi-omics reagent business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Immudex social profiles

Digital presence

Immudex compliance and trust

Trust signal

Compliance2 records

Immudex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Immudex leadership team

Management profile

Number of profiles

Profiles3 records

Immudex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Immudex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Immudex

What does Immudex do?

Immudex develops, manufactures, and commercializes Dextramer®-based biological reagents and related custom services for the detection, characterization, and generation of antigen-specific immune cells. Its portfolio spans flow cytometry reagents, DNA-barcoded reagents for NGS and single-cell multi-omics, GMP-grade clinical reagents, and T cell stimulation scaffolds, supported by a custom solutions team that develops new alleles, TCR reagents, and tailored assays for cell therapy developers, vaccine researchers, and academic immunology laboratories.

Is Immudex a public or private company?

Immudex is a private company. It is classified as unknown and is currently operating.

When was Immudex founded?

Immudex was founded in 2009. It employs 11 to 50 people.

Where is Immudex based?

Immudex is headquartered in Copenhagen, Denmark, in the Europe region.

How does Immudex make money?

Four revenue lines are on record. Research Reagent Sales are the primary driver. The others are custom Solutions and Services, clinical-Grade Reagents and xynapse™ Reagent Sales.

Who are Immudex's main competitors?

Direct peers on record are MBL International (JPT Peptide Technologies) and ProImmune. Broad incumbents are BioLegend (PerkinElmer), Beckman Coulter (Danaher), Thermo Fisher Scientific and Cell Signaling Technology (CST). Emerging players are 10x Genomics and BD Biosciences.

Does Immudex have an API?

No public API is recorded for Immudex.

What industry is Immudex in?

Immudex's product category is Immune Monitoring Reagents. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals